Recalls

Feb 28, 2017

The U.S. Food and Drug Administration has approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in people 18 through…

Jan 25, 2015

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces…

Dec 12, 2012

Newest FS Series 3 Module is Latest Milestone on Cost-Efficiency Roadmap TEMPE, Ariz.--(BUSINESS WIRE)-- First Solar, Inc. (Nasdaq: FSLR) has released of its most advanced thin-film photovoltaic (PV) module, the Series 3 FS-392, which is rated at 92.5 watts. The…

Oct 23, 2012

Secure Mobile Communication; compatible with any device and any network Chandler, AZ Cummings Engineering, in partnership with Ascent Rugged Mobile, is launching SAIFEâ„¢ Defender, the worlds first commercial rugged Android device with secure digital communications. The launch will be next…

Sep 11, 2012

Thinnest, Lightest iPhone Ever Features All-New Aluminum Design, Stunning 4-Inch Retina Display, A6 Chip & Ultrafast Wireless SAN FRANCISCO Apple® has introduced iPhone® 5, the thinnest and lightest iPhone ever, completely redesigned to feature a stunning new 4-inch Retinaâ„¢ display;…

Aug 30, 2012

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone. Approved for prostate cancer patients previously treated…